Ain Holdings Inc. · TSE:9627
Ain — Q1 FY4/23 Earnings Presentation
21 slides from Ain's earnings presentation, September 2022
Slide 1: FY4/23 1Q IR Presentation
FY4/23 1Q IR PRESENTATION September 2022
Slide 2: Results Overview
Results Overview © 2022 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 8.6% YoY and declined 0.5% against the plan despite the impact of the COVID-19. Ordinary profit increased 7.9% YoY and declined 2.9% against the plan due to increase of sales. FY4/22 1Q FY4/23 1Q FY4/23 1Q YoY YoY Vs plan （¥ million） results plan results change c
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 8.5% YoY and declined 0.5% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit declined 3.0% YoY and 12.2% against the plan. FY4/22 1Q FY4/23 1Q FY4/23 1Q YoY YoY Vs p
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales up 20.2% YoY and declined 0.7% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of the COVID-19. Segment profit was ¥164 million, ¥184 million above the plan. FY4/22
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥30,947 million and shareholdersʼ equity ratio became 52.0%. We are maintaining a sound financial structure even during the COVID-19 outbreak. End-FY4/22 (¥ million) End-FY4/23 1Q (¥ million) Assets Liabilities Assets Liabilities Current assets Current Current assets
Slide 7: Assets
Assets The balance of total assets increased ¥15,933 million from the end of the previous fiscal year due to decrease of cash on hand and in banks and increase of inventories and goodwill. (¥ million) End-FY4/22 1Q End-FY4/22 End-FY4/23 1Q Change Cash on hand and in banks 53,576 59,729 46,863 (12,86
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥8,706 million due to new store openings and M&A. Short-term and long-term debt increased ¥6,927 million. (¥ million) End-FY4/22 1Q End-FY4/22 End-FY4/23 1Q Change Accounts payable 49,094 50,756 59,462 +8,706 Short-term debt 3,354 2,643 4,167 +1,
Slide 9: FY4/23 Plan (Consolidated)
FY4/23 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2023 of ¥363,000 million, increase 14.8% YoY and ordinary profit of ¥20,500 million, increase 27.8% YoY. FY4/21 FY4/22 FY4/23 YoY YoY （¥ million） results results plan change change(%) Net sales 297,305 316,
Slide 10: Review
Review © 2022 AIN HOLDINGS INC. All Rights Reserved. 9
Slide 11: Daily new COVID-19 cases across Japan
Daily new COVID-19 cases across Japan As of September 1, the number of domestic cases of the COVID-19 infection and deaths was 19,116,887 and 40,245, respectively. （people） 300,000 Aug.2 263,535 Tokyo Olympics Tokyo Paralympics 250,000 Jul.23－Aug.8 Aug.24－Sep.5 200,000 pre-emergency state of emergen
Slide 12: Review (YoY)
Review (YoY) Ordinary profit increased ¥0.2 billion due to increase of net sales in both dispensing pharmacy and cosmetic and drug store businesses. Net sales +¥6.4 billion Ordinary profit +¥0.2 billion ¥81.4 billion +8.6% ¥75.0 billion ¥2.8 billion ¥3.0 billion +7.9% ■Dispensing ■Dispensing Pharmac
Slide 13: Strategy
Strategy © 2022 AIN HOLDINGS INC. All Rights Reserved. 12
Slide 14: Strategy
Strategy Expansion of top-line and increase profits ■Dispensing Pharmacy Plan to open 160 pharmacies（Organic 48, M&A 112） ■Cosmetic and Drug Store Plan to open 10 stores Recruiting and training of human resources ■Planning to hire 600 newly graduated pharmacists（hired 660 new pharmacists in FY4/22）
Slide 15: Expansion of top-line and increase profits
Expansion of top-line and increase profits 1 FY4/23 1Q Results FY4/23 Plan 1,289 1,332 Dispensing 1,210 Dispensing 1,249 109 Pharmacies Pharmacies Cosmetics and Cosmetics and 18 Drug stores 79 Drug stores 83 166 2 461 108 40 139 2 162 2 8 65 7 :Dispensing Pharmacies ︓Cosmetic and drug stores © 2022
Slide 16: Expansion of top-line and increase profits: Openings
Expansion of top-line and increase profits 2 ■ Plan FY4/23 1Q FY4/23 Plan Results Plan Dispensing Pharmacy 116 117 160 Organic 8 8 48 Opening 108 109 112 M&A 10 Cosmetic and drug store 2 2 170 Total 118 119 Dispensing Pharmacy 4 6 10 Closure Cosmetic and drug store 2 1 5 Total 6 7 15 Dispensing Phar
Slide 17: Recruiting and training of human resources
Recruiting and training of human resources In April 2022, new 660 pharmacists has joined our group. We aim to hire roughly the same number in fiscal 2023. As of July 31,2022, the group has 6,154 pharmacists out of 13,774 employees. （people） （people） 800 No. of newly-hired pharmacists 6,000 5,230 No.
Slide 18: AINZ & TULPE
AINZ & TULPE AINZ & TULPE plan to open in FY4/23 10 stores MOSAICMALL Kohoku KOBE MOTOMACHI (Opened in May 2022) (Opened in June 2022) FUTAKO TAMAGAWA RISE Tokyo (Plan to open in (Plan to open in October 2022) March 2023) © 2022 AIN HOLDINGS INC. All Rights Reserved. 17
Slide 19: FY4/23 Plan (Consolidated)
FY4/23 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2023 of ¥363,000 million, increase 14.8% YoY and ordinary profit of ¥20,500 million, increase 27.8% YoY. FY4/21 FY4/22 FY4/23 YoY YoY （¥ million） results results plan change change(%) Net sales 297,305 316,
Slide 20: Inquiries related to this presentation
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha
Slide 21: AIN GROUP
AIN GROUP